Akira Kanda Selected Research

Akira Kanda Research Topics

Disease

19	Inflammation (Inflammations) 02/2022 - 06/2004
15	Asthma (Bronchial Asthma) 02/2022 - 04/2003
8	Rhinosinusitis 07/2021 - 10/2014
5	Eosinophilia 02/2022 - 09/2009
4	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2017
3	Atopic Dermatitis (Atopic Eczema) 06/2014 - 04/2008
3	Pneumonia (Pneumonitis) 10/2011 - 04/2008
3	Respiratory Hypersensitivity 07/2010 - 04/2008
2	Infections 01/2021 - 12/2004
1	Airway Remodeling 02/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 09/2021
1	Wasting Syndrome (Wasting Disease) 09/2021
1	Seasonal Allergic Rhinitis (Hay Fever) 08/2021
1	Hearing Loss (Hearing Impairment) 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Nasal Obstruction 04/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2018
1	Paralysis (Palsy) 01/2017
1	Esophageal Neoplasms (Esophageal Cancer) 01/2017
1	Diphtheria 01/2015
1	Tetanus 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Sinusitis 10/2014
1	Hyperplasia 10/2011
1	B-Cell Leukemia (Leukemia, B Cell) 11/2010
1	Lymphoma (Lymphomas) 11/2010
1	Lung Diseases (Lung Disease) 11/2010
1	Hypersensitivity (Allergy) 07/2010

Drug/Important Bio-Agent (IBA)

7	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2021 - 01/2017
6	AntigensIBA 02/2022 - 02/2008
5	CytokinesIBA 02/2022 - 09/2009
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2021 - 01/2015
3	OvalbuminIBA 02/2019 - 04/2008
3	Interleukin-5 (Interleukin 5)IBA 02/2019 - 09/2009
3	Immunoglobulin E (IgE)IBA 10/2011 - 04/2008
3	AllergensIBA 11/2010 - 02/2008
3	PPAR gammaIBA 11/2005 - 04/2003
2	SteroidsIBA 02/2022 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2010
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2020 - 07/2010
2	VaccinesIBA 01/2015 - 05/2008
2	ChemokinesIBA 06/2014 - 07/2004
2	Immunoglobulin G (IgG)IBA 07/2010 - 04/2008
2	Prostaglandins DIBA 01/2007 - 01/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2022
1	Monoclonal AntibodiesIBA 02/2022
1	entrectinibIBA 01/2022
1	Nonsense Codon (Nonsense Mutation)IBA 09/2021
1	RNA Precursors (Precursor, mRNA)IBA 09/2021
1	Antisense OligonucleotidesIBA 09/2021
1	DystrophinIBA 09/2021
1	Pharmaceutical PreparationsIBA 08/2021
1	Omalizumab (Xolair)FDA Link 07/2021
1	FibrinIBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	lenvatinibIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2020
1	lysolecithin acylhydrolaseIBA 01/2019
1	Interleukin-22 (IL-22)IBA 01/2017
1	ExotoxinsIBA 01/2017
1	Formoterol Fumarate (Oxis)FDA Link 01/2017
1	Salmeterol Xinafoate (Serevent)FDA Link 01/2017
1	Serum AlbuminIBA 01/2017
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2017
1	interleukin-22 receptor (IL-22R)IBA 01/2017
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2015
1	Diphtheria-Tetanus VaccineIBA 01/2015
1	AntibodiesIBA 01/2015
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	ToxoidsIBA 01/2015
1	Amyloid beta-PeptidesIBA 01/2015
1	Protein Subunit VaccinesIBA 01/2015
1	Therapeutic UsesIBA 10/2014
1	Chemokine CX3CL1IBA 06/2014
1	Chemokine ReceptorsIBA 06/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011
1	Methacholine Chloride (Methacholine)FDA Link 10/2011
1	Indicators and Reagents (Reagents)IBA 11/2010
1	Interleukin-10 (Interleukin 10)IBA 07/2010
1	Isoantigens (Alloantigen)IBA 07/2010
1	Interleukin-4 (Interleukin 4)IBA 07/2010
1	Interleukin-13IBA 07/2010
1	CollagenIBA 09/2009

Therapy/Procedure

4	Therapeutics 02/2022 - 10/2011
1	Intraperitoneal Injections 02/2019
1	Cholecystectomy 01/2019
1	Neck Dissection (Radical Neck Dissection) 10/2018
1	Metered Dose Inhalers (Metered Dose Inhaler) 01/2018
1	Dry Powder Inhalers 01/2017
1	Esophagectomy 01/2017
1	Nebulizers and Vaporizers (Inhaler) 10/2014
1	Aftercare (After-Treatment) 10/2014